Efficiency of retroviral transduction into hematopoietic cells by cocultivation procedure does not correlate with viral titer

Cancer Gene Therapy

Volumn 4, Issue 1, 1997, Pages 5-8

  Bagnis, Claude ^a   Chischportich, Celia ^a   Imbert, Anne Marie ^a   Van Den Broeke, Anne ^b   Cornet, Véronique ^a   Mannoni, Patrice ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Human hematopoietic cells; LacZ; Retroviral vector; Transduction efficiency; Viral titer

Indexed keywords

ARTICLE; BONE MARROW CELL; CELL LINE; GENE TRANSFER; GENETIC TRANSDUCTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LACTOSE OPERON; RETROVIRUS;

BONE MARROW CELLS; CELL LINE; GENE TRANSFER TECHNIQUES; HUMANS; LAC OPERON; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 0030641847     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nienhuis AW, McDonagh KT, Bodine DM. Gene transfer into hematopoietic stem cells. Cancer. 1991;67:2700-2704.
2. Maher J, Colonna F, Baker D, Luzzatto L, et. al. Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation. Exp Hematol. 1994;22:8-12.
3. Culver KW, Blaese M. Gene therapy for cancer. Trends Genet. 1994;10:174-178.
4. Mulligan RC. The basic science of gene therapy. Science. 1993;260:926-932.
5. Federico M, Nappi F, Ferrari G, et. al. A non producer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/pseudotype retrovirus. J Virol. 1995;69:6618-6626.
6. Imbert AM, Costello R, Imbert J, et. al. Highly efficient retroviral gene transfer into human primary T-lymphocytes derived from the peripheral blood. Cancer Gene Ther. 1994;1:259-265.
7. Bagnis C, Gravis G, Imbert AM, et al. Retroviral transfer of the nlsLacZ gene into human CD34+ cell populations and into TF-1 cells: future prospects in gene therapy. Hum Gene Ther. 1994;5:1325-1333.
8. Nolta JA, Crooks GM, Overell RW, et al. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: effects of mast cell growth factor (MGF) combined with other cytokines. Exp Hematol. 1992;20:1065-1071.
9. Friedrich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Gene Dev. 1991;5:1513-1523.
10. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA. 1988;85: 6460-6464.
11. Nolan GP, Fiering S, Nicolas JF, Herzenberg LA. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of E. coli LacZ. Proc Natl Acad Sci USA. 1988;85:2603-2607.
12. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient packaging cell line. Virology. 1988;167: 400-406.
13. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol. 1988;62:1120-1124.
14. Kitamura T, Tange T, Terasawa T, et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol. 1989;140:323-334.
15. Kettman R, Cleuter Y, Gregoire D, Burny A. Role of the 3′ long open reading frame region of the bovine leukemia virus in the maintenance of cell transformation. J Virol. 1985;54:899-901.
16. Bagnis C, Cosset FL, Samarut J, et al. Leukemogenicity of v-myb transformed monoblasts cells can be modulated by normal bone marrow environment. Oncogene. 1993;8:737-743.
17. MacGregor GR, Mogg AE, Burke JF, Caskey CT. Histochemical staining of clonal mammalian cell lines expressing E. coli β-galactosidase indicates heterogeneous expression of the bacterial gene. Somat Cell Mol Genet. 1987;13: 253-265.
18. Miller AD, Garcia JV, von Suhr N, et al. Construction and properties of retrovirus packaging cells based on Gibbon ape leukemia virus. J Virol. 1991;65:2220-2224.
19. van Beusechem VW, Bakx TA, Kaptein LCM, et al. Retrovirus-mediated gene transfer into rhesus monkey hematopoietic stem cells: the effect of viral titers on transduction efficiency. Hum Gene Ther. 1993;4:239-247.
20. Issaad C, Croisille L, Katz A, et al. A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays. Blood. 1993;81:2916-2924.
21. Xu LC, Young HA, Blanco M, et al. Poor transduction efficiency of human hematopoietic progenitor cells by a high titer amphotropic retrovirus producer cell clone. J Virol. 1994;68:7634-7636.
22. Heinrich MC, Dooley DC, Keeble WW. Transforming growth factor β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood. 1995;85: 1769-1780.
23. Mayani H, Little MT, Dragowska W, et al. Differential effects of the hematopoietic inhibitors MIP-1α, TGF-beta, and TNFα on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Exp Hematol. 1995;23:422-427.
24. Forestell SP, Bohnlein E, Rigg RJ. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther. 1995;2:723-730.